Remigromig in DME: What BRUNELLO Shows and What BAROLO Must Answer
Join Drs. Rishi Singh and Donald D'Amico to review the results of the phase 3 BRUNELLO trial of Remigromig for DME and implications for the BAROLO trial.
New Content
Clinical Studies & Trials
Beyond Monotherapy: What the APL-3007 Combination Trial Signals About the Next Phase of Complement Therapy
October 16, 2026
Diagnostics & Imaging
Structure-Function Correlation in GA: Why Microperimetry Is Entering the Conversation
October 9, 2026
Recently Published
CLINICAL STUDIES & TRIALS
Beyond Compounding: An FDA-Approved Bevacizumab Option for Wet AMD
Join Rishi P. Singh, MD, FASRS and Bob Jahr of Outlook Therapeutics as they discuss the FDA approval of bevacizumab.
Rishi P. Singh, MD, FASRS, Bob JahrSeptember 30, 2026
CLINICAL GUIDES
Realities of Inherited Retinal Disease: Patient Perspectives and Pearls
Join Drs. Rishi P. Singh and Aaron Nagiel as they discuss the unique challenges that patients with inherited retinal diseases (IRDs) face in getting treatment.
Rishi P. Singh, MD, FASRS, Aaron Nagiel, MD, PhDSeptember 24, 2026
CASE REPORTS
Taking a Closer Look at Cosmetic Laser Retinopathy
Sit down with Drs. Rishi P. Singh and Jimmy S. Chen to review a case of choroidal neovascularization following at-home cosmetic laser exposure.
Rishi P. Singh, MD, FASRS, Jimmy S. Chen, MDSeptember 22, 2026
CLINICAL STUDIES & TRIALS
A Look at the Latest for Gene Therapies for Inherited Retinal Diseases
Rishi P. Singh, MD, FASRS, George Magrath, MD, MBA, MSSeptember 15, 2026
CLINICAL STUDIES & TRIALS
Oculis' Pioneer Program: Optic Neuritis as a Proof of Concept for Retinal Neuroprotection
Rishi P. Singh, MD, FASRS, Riad Sherif, MDAugust 31, 2026
PRACTICE MANAGEMENT
Putting a Laser Focus on Choosing the Right Equipment for Your Practice
Rishi P. Singh, MD, FASRS, Louis Cai, MDAugust 28, 2026
